Cardio SARE: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Cardio SARE
Largest movements
- Cash -€21,377
down €21,377 (-35.1%), from €60,951 to €39,574
mainly Trade debts (-€26,958) and Net result for the year (-€9,686)
- Receivables within one year -€15,267
down €15,267 (-6.0%), from €253,154 to €237,887
of which Trade receivables: -€15,267
- Trade debts -€26,958
down €26,958 (-10.7%), from €251,802 to €224,844
- Profit (loss) carried forward -€9,686
down €9,686 (-17.9%), from €54,242 to €44,556
- Gross operating margin -€18,205
down €18,205, from €9,062 to -€9,144
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €314,105 | €277,460 | -€36,644 | -11.7% |
| Current assets | 29/58 | €314,105 | €277,460 | -€36,644 | -11.7% |
| Amounts receivable within one year | 40/41 | €253,154 | €237,887 | -€15,267 | -6.0% |
| Trade receivables | 40 | €249,975 | €234,708 | -€15,267 | -6.1% |
| Other amounts receivable | 41 | €3,179 | €3,179 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €60,951 | €39,574 | -€21,377 | -35.1% |
| Total equity and liabilities | 10/49 | €314,105 | €277,460 | -€36,644 | -11.7% |
| Equity | 10/15 | €62,302 | €52,616 | -€9,686 | -15.5% |
| Contributions | 10/11 | €6,200 | €6,200 | = | 0.0% |
| Contributions outside capital | 11 | €6,200 | €6,200 | = | 0.0% |
| Other | 1109/19 | €6,200 | €6,200 | = | 0.0% |
| Reserves | 13 | €1,860 | €1,860 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Profit (loss) carried forward | 14 | €54,242 | €44,556 | -€9,686 | -17.9% |
| Amounts payable | 17/49 | €251,802 | €224,844 | -€26,958 | -10.7% |
| Amounts payable within one year | 42/48 | €251,802 | €224,844 | -€26,958 | -10.7% |
| Trade debts | 44 | €251,802 | €224,844 | -€26,958 | -10.7% |
| Suppliers | 440/4 | €251,802 | €224,844 | -€26,958 | -10.7% |
| Other operating charges | 640/8 | €386 | €387 | +€1 | +0.2% |
| Gross operating margin | 9900 | €9,062 | -€9,144 | -€18,205 | |
| Operating profit (loss) | 9901 | €8,675 | -€9,531 | -€18,206 | |
| Financial charges | 65/66B | €177 | €155 | -€22 | -12.5% |
| Recurring financial charges | 65 | €177 | €155 | -€22 | -12.5% |
| Profit (loss) for the period before taxes | 9903 | €8,498 | -€9,686 | -€18,184 | |
| Profit (loss) for the period | 9904 | €8,498 | -€9,686 | -€18,184 | |
| Profit (loss) for the period to be appropriated | 9905 | €8,498 | -€9,686 | -€18,184 |
Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 25 October 2026 via checked.be.